Marimed Return On Equity vs. Current Valuation

MRMD Stock  USD 0.15  0.01  7.14%   
Based on the measurements of profitability obtained from Marimed's financial statements, Marimed may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Marimed's ability to earn profits and add value for shareholders.
For Marimed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Marimed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Marimed utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Marimed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Marimed over time as well as its relative position and ranking within its peers.
  
Check out Correlation Analysis.
Please note, there is a significant difference between Marimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Marimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Marimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Marimed Current Valuation vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Marimed's current stock value. Our valuation model uses many indicators to compare Marimed value to that of its competitors to determine the firm's financial worth.
Marimed is considered to be number one stock in return on equity category among its peers. It also is rated top company in current valuation category among its peers reporting about  5,891,330,330  of Current Valuation per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Marimed's earnings, one of the primary drivers of an investment's value.

Marimed Current Valuation vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Marimed

Return On Equity

 = 

Net Income

Total Equity

 = 
0.0303
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Marimed

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
178.51 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Marimed Current Valuation vs Competition

Marimed is rated top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Drug Manufacturers—Specialty & Generic industry is now estimated at about 4.71 Billion. Marimed holds roughly 178.51 Million in current valuation claiming about 4% of equities under Drug Manufacturers—Specialty & Generic industry.

Marimed Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Marimed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Marimed will eventually generate negative long term returns. The profitability progress is the general direction of Marimed's change in net profit over the period of time. It can combine multiple indicators of Marimed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts. Marimed operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 260 people.

Marimed Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Marimed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Marimed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Marimed's important profitability drivers and their relationship over time.

Use Marimed in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Marimed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marimed will appreciate offsetting losses from the drop in the long position's value.

Marimed Pair Trading

Marimed Pair Trading Analysis

The ability to find closely correlated positions to Marimed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Marimed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Marimed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Marimed to buy it.
The correlation of Marimed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Marimed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Marimed moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Marimed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Marimed position

In addition to having Marimed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Communication Services Thematic Idea Now

Communication Services
Communication Services Theme
Companies that provide networking, telecom, and long distance services. The Communication Services theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Communication Services Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Marimed OTC Stock

To fully project Marimed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Marimed at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Marimed's income statement, its balance sheet, and the statement of cash flows.
Potential Marimed investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Marimed investors may work on each financial statement separately, they are all related. The changes in Marimed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Marimed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.